Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
ARTICLE, Cellular/Molecular

Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes Is an Early Event Triggered by Status Epilepticus

Yunfei Huang, James J. Doherty and Ray Dingledine
Journal of Neuroscience 1 October 2002, 22 (19) 8422-8428; https://doi.org/10.1523/JNEUROSCI.22-19-08422.2002
Yunfei Huang
1Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James J. Doherty
1Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ray Dingledine
1Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Transcriptional control of GluR2 expression.A, Model of transcriptional repression mediated by the transcriptional repressor REST, which binds the RE1 element. Both N-terminal (Huang et al., 1999) and C-terminal (Ballas et al., 2001) repressor domains recruit histone deacetylase complexes (HDAC), which contain the Siu3 or CoREST corepressors. B, Nissl-stained sections through the hippocampus 6 and 24 hr after pilocarpine treatment, showing thinning of the pyramidal cell layers at 24 but not 6 hr. Dashed triangle, The region of rat hippocampal slices that was microdissected for assays. con, Control.C, Downregulation of GluR2 mRNA in CA3 after pilocarpine. GluR2 and GAPDH mRNA levels were measured by RNase protection assay at 3, 16, and 24 hr after pilocarpine treatment. GluR2 PCR band signals were normalized to GAPDH. Data are presented as mean ± SEM of percentage to their controls (n= 3–4; *p < 0.05 from 0 hr control).

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Reduction of histone H4 acetylation over GluR2 promoter after status epilepticus. A, Schematic of the ChIP procedure. IP, Immunoprecipitation.B, Genomic DNA was collected from the hippocampal CA3 region at 3, 8, 24, and 48 hr after injection of pilocarpine (pilo) and immunoprecipitated with anti-acetyl histone H3 (AcH3) or acetyl histone H4 (AcH4) antibodies (Ab) as indicated. Immunoprecipitated GluR2 genomic DNA fragments were detected by PCR. The graph shows the relative intensities of GluR2 PCR bands in acetyl histone H4 lanes. GluR2 band intensities at each time point were first normalized to their DNA inputs and then expressed as a percentage of control at the 0 time point. Input DNA levels were measured on ethidium bromide agarose plates as described in Materials and Methods. Immunoprecipitations performed without a primary antibody resulted in no PCR bands. Data are presented as mean ± SEM of percentage to the untreated or sham-treated control tissues (n = 3–8; *p < 0.05 by ANOVA and post hocDunnett's test).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    BDNF upregulation and hyperacetylation of upstream BDNF promoters after status epilepticus. A, The location of the four BDNF promoters (P1–P4) relative to each other is shown. Each BDNF transcript consists of exon 5 and one of the 5′ alternative exons derived from their corresponding promoters. Promoters P1 and P2 are separated by only 563 bp, and P3 and P4 are separated by only 802 bp, whereas promoters P2 and P3 are separated by ∼15 kb.B, Total RNA was isolated from the CA3 region of rats that had experienced 3 hr of pilocarpine (pilo) treatment or from sham controls, as indicated. BDNF exons I, II, III, and IV were amplified by reverse transcription-PCR with 26 cycles. GAPDH mRNA was also amplified as a control. C1, Hippocampal CA3 regions were collected 3 hr after pilocarpine treatment or from sham controls. DNA representing BDNF promoters P1–P4 was amplified by PCR from genomic DNA fragments that had been precipitated by anti-acetyl H4 (AcH4) antibodies (Ab). C2, The level of BDNF P2 promoter associated with acetyl histone H4 was increased and that of the P4 promoter was decreased after status epilepticus (n= 5; *p < 0.05 from untreated or sham-treated controls; ANOVA and post hoc Newman–Keuls test). Thedashed line indicates 100% level.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Trichostatin A prevents SE-induced histone deacetylation at the GluR2 promoter in the CA3 region. Rats cannulated in the lateral ventricle were injected with 1 mg of TSA in 5 ml 1 hr before pilocarpine injection. ChIP samples were prepared from the hippocampal CA3 region 3 hr after pilocarpine treatment.A, Precipitated GluR2 genomic DNA fragments were detected by PCR. AcH4, Acetyl histone H4;pilo, pilocarpine. B, After normalization of the PCR band signals in the acetyl histone H4 lanesto their DNA input levels, data are presented as mean ± SEM of percentage to the untreated or sham-treated controls (n = 14; *p < 0.05). All data sets passed the Kolmogorov–Smirnov test for normal distribution. Analysis of the same data by the nonparametric Wilcoxon signed rank test confirmed that only the pilocarpine condition was different (p < 0.05) from control.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    TSA reverses SE-induced histone deacetylation at the GluR2 promoter in the CA3 region. Brain slices prepared from rats after 3 hr of status epilepticus induced by pilocarpine were incubated in ACSF with or without 300 nm TSA for an additional 3 hr.A, Immunoprecipitated GluR2 genomic DNA fragments were detected by PCR. AcH4, Acetyl histone H4;Pilo, pilocarpine. B, After normalization of the PCR band signals in the H4 lanes to their inputs, data are presented as mean ± SEM of percentage to their untreated or sham-treated controls (n = 4; *p < 0.05).

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Trichostatin A reverses pilocarpine-induced downregulation of GluR2 mRNA. Brain slices were prepared from rats that had experienced 3 hr of pilocarpine-induced status epilepticus and incubated in ACSF with or without 300 nm TSA for 7 hr. Total RNA was then prepared from CA3 regions. A, GluR2 and GAPDH mRNA levels were measured by RNase protection.B, GluR2 mRNA normalized to GAPDH is shown for the four conditions. Data are presented as mean ± SEM of percentage to their untreated or sham-treated controls (n = 3; *p < 0.05).

Back to top

In this issue

The Journal of Neuroscience: 22 (19)
Journal of Neuroscience
Vol. 22, Issue 19
1 Oct 2002
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes Is an Early Event Triggered by Status Epilepticus
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes Is an Early Event Triggered by Status Epilepticus
Yunfei Huang, James J. Doherty, Ray Dingledine
Journal of Neuroscience 1 October 2002, 22 (19) 8422-8428; DOI: 10.1523/JNEUROSCI.22-19-08422.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes Is an Early Event Triggered by Status Epilepticus
Yunfei Huang, James J. Doherty, Ray Dingledine
Journal of Neuroscience 1 October 2002, 22 (19) 8422-8428; DOI: 10.1523/JNEUROSCI.22-19-08422.2002
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • bdnf
  • histone deacetylase
  • histone acetyltransferase
  • hippocampus
  • seizure
  • gene expression
  • glutamate
  • neurodegeneration
  • neuroprotection
  • GluR2
  • GRIA2

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

ARTICLE

  • Salicylate Induces Tinnitus through Activation of Cochlear NMDA Receptors
  • Developmental Increase in Vesicular Glutamate Content Does Not Cause Saturation of AMPA Receptors at the Calyx of Held Synapse
  • Visuomotor Behaviors in Larval Zebrafish after GFP-Guided Laser Ablation of the Optic Tectum
Show more ARTICLE

Cellular/Molecular

  • Co-release of GABA and ACh from Medial Olivocochlear Neurons as a Fine Regulatory Mechanism of Cochlear Efferent Inhibition
  • Synaptic Gpr85 influences cerebellar granule cells electrical properties and light-induced behavior in zebrafish.
  • Cofilin Inhibition Ameliorates PIEZO2 and AMPA Dysfunction in a Mouse Model of Angelman Syndrome
Show more Cellular/Molecular
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.